| 8627649 | CV82793 | single nucleotide variant | NM_024063.2(SPATA5L1):c.2182C>T (p.Pro728Ser) | Malignant melanoma [RCV000062873] | not provided | 15 | 45421130 | 45421130 | Human | | name |
| 8635482 | CV90703 | single nucleotide variant | NM_024063.2(SPATA5L1):c.1126G>A (p.Glu376Lys) | Malignant melanoma [RCV000070801] | not provided | 15 | 45405356 | 45405356 | Human | | name |
| 38598843 | CV964865 | single nucleotide variant | NM_024063.3(AFG2B):c.1090-2A>G | SPATA5L1-associated disorder [RCV001254127] | pathogenic | 15 | 45405318 | 45405318 | Human | | trait |
| 38598848 | CV964868 | single nucleotide variant | NM_024063.3(AFG2B):c.1973G>A (p.Arg658Lys) | SPATA5L1-associated disorder [RCV001254130] | likely pathogenic | 15 | 45418561 | 45418561 | Human | | trait |
| 38598850 | CV964870 | deletion | NM_024063.3(AFG2B):c.2176_2177del (p.Val726fs) | SPATA5L1-associated disorder [RCV001254132] | pathogenic | 15 | 45421123 | 45421124 | Human | | trait |
| 153348485 | CV1692522 | single nucleotide variant | NM_024063.3(AFG2B):c.2087G>T (p.Cys696Phe) | Neurodevelopmental delay [RCV002274376]|SPATA5L1-related disorder [RCV005429080]|not provided [RCV003320882] | likely pathogenic|uncertain significance|not provided | 15 | 45418675 | 45418675 | Human | 2 | trait |
| 38598898 | CV964864 | single nucleotide variant | NM_024063.3(AFG2B):c.527G>T (p.Gly176Val) | AFG2B-related disorder [RCV003416130]|Hearing loss, autosomal recessive 119 [RCV001779143]|Inborn genetic diseases [RCV005328661]|Neurodevelopmental delay [RCV002274164]|Neurodevelopmental disorder with hearing loss and spasticity [RCV001779144]|SPATA5L1-associa ted disorder [RCV001254169]|SPATA5L1-related disorder [RCV005429052]|See cases [RCV001580190]|not provided [RCV001879881] | pathogenic|likely pathogenic|not provided | 15 | 45402956 | 45402956 | Human | 4 | trait |
| 38598844 | CV964866 | single nucleotide variant | NM_024063.3(AFG2B):c.1199C>T (p.Thr400Ile) | AFG2B-related disorder [RCV003399031]|Neurodevelopmental disorder with hearing loss and spasticity [RCV001779141]|SPATA5L1-associated disorder [RCV001254128]|See cases [RCV001838468]|not provided [RCV003883592] | pathogenic|likely pathogenic | 15 | 45405429 | 45405429 | Human | 2 | trait |
| 38598846 | CV964867 | single nucleotide variant | NM_024063.3(AFG2B):c.1556C>A (p.Ala519Asp) | Neurodevelopmental disorder with hearing loss and spasticity [RCV002290666]|SPATA5L1-associated disorder [RCV001254129] | likely pathogenic|uncertain significance | 15 | 45414692 | 45414692 | Human | 1 | trait |
| 38598849 | CV964869 | single nucleotide variant | NM_024063.3(AFG2B):c.2006T>G (p.Met669Arg) | Neurodevelopmental disorder with hearing loss and spasticity [RCV001779142]|SPATA5L1-associated disorder [RCV001254131] | pathogenic|likely pathogenic | 15 | 45418594 | 45418594 | Human | 1 | trait |